Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 511 AL 525

Pathophysiological mechanism and natural preventive and therapeutic strategies of Alzheimer's disease

Basli A, Bounaas J.

Nutr Health. 2023 Sep;29(3):403-413. doi: 10.1177/02601060221137104. Epub 2022 Nov 14.

Ginsenoside Rg1 in neurological diseases: From bench to bedside

Yang SJ, Wang JJ, Cheng P, Chen LX, Hu JM, Zhu GQ.

Acta Pharmacol Sin. 2023 May;44(5):913-930. doi: 10.1038/s41401-022-01022-1. Epub 2022 Nov 15.

Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights

Oliyaei N, Moosavi-Nasab M, Tanideh N, Iraji A.

Brain Res Bull. 2023 Feb;193:11-21. doi: 10.1016/j.brainresbull.2022.11.018. Epub 2022 Nov 23.

Exosome-based approaches in the management of Alzheimer's disease

Kandimalla R, Saeed M, Tyagi N, Gupta RC, Aqil F.

Neurosci Biobehav Rev. 2023 Jan;144:104974. doi: 10.1016/j.neubiorev.2022.104974. Epub 2022 Nov 23.

The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators

Chen LL, Fan YG, Zhao LX, Zhang Q, Wang ZY.

Bioorg Chem. 2023 Feb;131:106301. doi: 10.1016/j.bioorg.2022.106301. Epub 2022 Nov 25.

Postulating the possible cellular signalling mechanisms of antibody drug conjugates in Alzheimer's disease

Punyakoti P, Behl T, Sehgal A, Yadav S, Sachdeva M, Anwer MK, Vargas-De-La-Cruz C, Venkatachalam T, Naqvi M, Verma R, Tuli HS.

Cell Signal. 2023 Feb;102:110539. doi: 10.1016/j.cellsig.2022.110539. Epub 2022 Nov 29.

The ameliorative effects and mechanisms of abscisic acid on learning and memory

Liao P, Wu QY, Li S, Hu KB, Liu HL, Wang HY, Long ZY, Lu XM, Wang YT.

Neuropharmacology. 2023 Feb 15;224:109365. doi: 10.1016/j.neuropharm.2022.109365. Epub 2022 Nov 30.

Beyond the classical amyloid hypothesis in Alzheimer's disease: Molecular insights into current concepts of pathogenesis, therapeutic targets, and study models

Theerasri A, Janpaijit S, Tencomnao T, Prasansuklab A.

WIREs Mech Dis. 2023 Mar;15(2):e1591. doi: 10.1002/wsbm.1591. Epub 2022 Dec 9.

Unmasking BACE1 in aging and age-related diseases

Bao H, Shen Y.

Trends Mol Med. 2023 Feb;29(2):99-111. doi: 10.1016/j.molmed.2022.11.008. Epub 2022 Dec 9.

Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer's disease

Neha, Parvez S.

Ageing Res Rev. 2023 Mar;85:101815. doi: 10.1016/j.arr.2022.101815. Epub 2022 Dec 16.

Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders

Kaur P, Khera A, Alajangi HK, Sharma A, Jaiswal PK, Singh G, Barnwal RP.

Mol Neurobiol. 2023 Mar;60(3):1690-1720. doi: 10.1007/s12035-022-03164-z. Epub 2022 Dec 23.

The role of adenosine A(2A) receptors in Alzheimer's disease and tauopathies

Launay A, Nebie O, Vijaya Shankara J, Lebouvier T, Buée L, Faivre E, Blum D.

Neuropharmacology. 2023 Mar 15;226:109379. doi: 10.1016/j.neuropharm.2022.109379. Epub 2022 Dec 23.

Role of multi-targeted bioactive natural molecules and their derivatives in the treatment of Alzheimer's disease: an insight into structure-activity relationship

Halder D, Das S, R S J, Joseph A.

J Biomol Struct Dyn. 2023 Dec;41(20):11286-11323. doi: 10.1080/07391102.2022.2158136. Epub 2022 Dec 29.

Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies

Imbimbo BP, Ippati S, Watling M, Imbimbo C.

Pharmacol Res. 2023 Jan;187:106631. doi: 10.1016/j.phrs.2022.106631. Epub 2022 Dec 28.

Noradrenergic therapies for apathy in Alzheimer's disease?

Husain M.

J Neurol Neurosurg Psychiatry. 2023 Feb;94(2):93. doi: 10.1136/jnnp-2022-330824. Epub 2022 Dec 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias